Bevacizumab beyond progression: Does this make sense?

Lee M. Ellis; Daniel G. Haller

doi:10.1200/JCO.2008.17.4540

Bevacizumab beyond progression: Does this make sense?

Lee M. Ellis, Daniel G. Haller

Surgical Oncology

Research output: Contribution to journal › Editorial › peer-review

31 Scopus citations

Original language	English (US)
Pages (from-to)	5313-5315
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	26
Issue number	33
DOIs	https://doi.org/10.1200/JCO.2008.17.4540
State	Published - Nov 20 2008

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2008.17.4540

Cite this

@article{b3128a5d09544bb79d37679156aa048e,

title = "Bevacizumab beyond progression: Does this make sense?",

author = "Ellis, {Lee M.} and Haller, {Daniel G.}",

year = "2008",

month = nov,

day = "20",

doi = "10.1200/JCO.2008.17.4540",

language = "English (US)",

volume = "26",

pages = "5313--5315",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "33",

}

TY - JOUR

T1 - Bevacizumab beyond progression

T2 - Does this make sense?

AU - Ellis, Lee M.

AU - Haller, Daniel G.

PY - 2008/11/20

Y1 - 2008/11/20

UR - http://www.scopus.com/inward/record.url?scp=56749182275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749182275&partnerID=8YFLogxK

U2 - 10.1200/JCO.2008.17.4540

DO - 10.1200/JCO.2008.17.4540

M3 - Editorial

C2 - 18854567

AN - SCOPUS:56749182275

SN - 0732-183X

VL - 26

SP - 5313

EP - 5315

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 33

ER -

Bevacizumab beyond progression: Does this make sense?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this